| 1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI) |
775351-65-0 |
775351-65-0 |
| THIQ |
THIQ |
312637-48-2 |
| TRIPELENNAMINE HYDROCHLORIDE |
盐酸曲吡那敏 |
154-69-8 |
| JJKK 048 |
1515855-97-6 |
1515855-97-6 |
| 5H-Benzocycloheptene-8-carboxylic acid, 3,4,6-trihydroxy-2-methoxy-5-oxo-, hexyl ester |
1416324-85-0 |
1416324-85-0 |
| Ca2+ channel agonist 1 |
1402821-24-2 |
1402821-24-2 |
| LOC-14 |
2-((4-(环丙烷羰基)哌嗪-1-基)甲基)苯并[D]异噻唑-3(2H)-酮 |
877963-94-5 |
| A-196 |
1982372-88-2 |
1982372-88-2 |
| Psoralenoside |
补骨脂苷 |
905954-17-8 |
| Ripasudil hydrochloride dihydrate |
(2S)-1-[(4-氟-5-异喹啉基)磺酰基]六氢-2-甲基-1H-1,4-二氮杂卓单盐酸盐二水合物 |
887375-67-9 |
| ETC-1002 |
贝派地酸 |
738606-46-7 |
| AC 186 |
化合物 T26537 |
1421854-16-1 |
| GV-58 |
(2R)-2-[[6-[[(5-甲基噻吩-2-基)甲基]氨基]-9-丙基-9H-嘌呤-2-基]氨基]丁烷-1-醇 |
1402821-41-3 |
| ME0328 |
ME0328 |
1445251-22-8 |
| CP21R7(CP21) |
GSK-3Β抑制剂(CP21R7) |
125314-13-8 |
| GSK 2830371 |
GSK 2830371 |
1404456-53-6 |
| TC-O 9311 |
TC-O 9311 |
444932-31-4 |
| SR8278 |
SR8278;SR-8278;SR 8278 |
1254944-66-5 |
| SR-95531 |
克他命 |
104104-50-9 |
| PRL-3 INHIBITOR I |
PRL-3 INHIBITOR I |
893449-38-2 |
